ArticleJournal of clinical pharmacology2026
Assessment of the Drug-Drug Interaction Potential of Lotiglipron (PF-07081532) with Midazolam, Omeprazole, Dabigatran, Rosuvastatin, and the Oral Contraceptives Levonorgestrel and Ethinyl Estradiol.
Carol Cronenberger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.